Netherlands· NL-03df23db2822

Dexamfetamine A.forall 5 mg tabletten

A dexamfetamine product containing dexamfetaminesulfaat, registered in Netherlands by A.Forall Access Limited. The same ATC class is registered in 14 of our 19 countries.

ATC N06BA02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dexamfetaminesulfaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dexamfetamine is registered in 14 of 19 countries.

Countries holding a registration under ATC N06BA02 (dexamfetamine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search dexamfetamine products by name

Dexamfetamine · ATC N06BA02

14 / 19 countries

Belgiumprice
Canada
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dexamfetamine costs, country by country.

Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Dexamfetamine · price per daily dose (15 mg)

USD · FX 28 Sept 2026

CH Switzerland$4.49

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: DEXAMFETAMINESULFAAT
Manufacturer: A.Forall Access Limited
Country: Netherlands (NL)
ATC code: N06BA02
ATC class: Dexamfetamine
Defined daily dose: 15 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
134977

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for dexamfetamine.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check dexamfetamine against other medicines How interaction checks work

Dexamfetamine · interactions on record

89 records

16 severe
73 moderate

Most severe, free to view

FenfluramineA08AA02severe
DexfenfluramineA08AA04severe
SibutramineA08AA10severe
ProcarbazineL01XB01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dexamfetamine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexamfetamine products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

Austria · Philla
Belgium · Adhesa, Attentin
Germany · Attentin, Dexamfetamin Orifarm
Denmark · Adhesa, Attentin
Estonia · Tentin
Spain · Tentin
Finland · Adhesa 5 Mg Tabletti, Attadex
France · Tentin
United Kingdom (Northern Ireland) · Amfexa, Dexamfetamine Sulfate
Iceland · Attentin, Dexamfetamine Taw Pharma (Ireland)
Italy · Amfexa
Luxembourg · Attentin
Malta · Dexamfetamine Sulfate
Norway · Attentin, Deksamfetamin Waymade B.V.
Poland · Tentin
Portugal · Tentin
Sweden · Attentin, Dexamfetamin Sea Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/991ec5a6-53b9-43ed-827d-bc19f47bc691
GET /v1/drugs/991ec5a6-53b9-43ed-827d-bc19f47bc691?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134977_smpc.pdf",
  "strength": null,
  "atc_label": "Dexamfetamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134977",
  "excipients": [
    "CROSPOVIDON (E 1202)",
    "ISOMALT (E 953)",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "DEXAMFETAMINESULFAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134977.pdf",
  "authorised_at": "2026/08/17",
  "procedure_number": "DE/H/8403/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134977",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about dexamfetamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console